Apogee Therapeutics (APGE) Stock Chart & Stock Price History $37.79 +0.94 (+2.55%) Closing price 04:00 PM EasternExtended Trading$37.81 +0.02 (+0.05%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Apogee Therapeutics Stock Price Performance 5 Day Performance+3.45%1 Month Performance-4.86%3 Month Performance-5.83%6 Month Performance-31.18%Year-To-Date Performance-16.58%1 Year Performance-19.82% Receive APGE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Apogee Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address APGE Stock Chart for Monday, April, 28, 2025 APGE Chart by TradingView Apogee Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/28/2025$36.85$37.79+2.55%$38.10$36.75484,306 shs$1.70 billion04/25/2025$37.05$36.85-0.54%$37.17$35.84578,730 shs$1.66 billion04/24/2025$36.53$37.05+1.42%$37.25$35.80341,561 shs$1.67 billion04/23/2025$35.50$36.53+2.90%$38.75$36.50590,468 shs$1.64 billion04/22/2025$32.85$35.50+8.07%$35.66$33.30813,499 shs$1.60 billion04/21/2025$33.11$32.85-0.79%$35.17$32.36503,404 shs$1.48 billion04/18/2025$33.11$33.11$33.38$31.60347,971 shs$1.49 billion04/17/2025$32.04$33.11+3.34%$33.38$31.60347,971 shs$1.49 billion04/16/2025$32.85$32.04-2.47%$33.08$31.38678,395 shs$1.44 billion04/15/2025$33.28$32.85-1.29%$34.23$32.03638,101 shs$1.48 billion Get the Latest News and Ratings for APGE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Apogee Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/14/2025$31.80$33.28+4.65%$34.05$31.21519,190 shs$1.50 billion04/11/2025$29.94$31.80+6.21%$31.90$28.60709,106 shs$1.43 billion04/10/2025$31.80$29.94-5.85%$30.76$28.86956,382 shs$1.35 billion04/09/2025$28.79$31.80+10.46%$32.82$27.151.61 million shs$1.43 billion04/09/2025$28.79$31.80+10.46%$32.82$27.151.61 million shs$1.43 billion04/08/2025$32.30$28.79-10.87%$34.38$26.201.52 million shs$1.30 billion04/08/2025$32.30$28.79-10.87%$34.38$26.201.52 million shs$1.30 billion04/07/2025$32.32$32.30-0.06%$32.76$29.64871,002 shs$1.45 billion04/04/2025$34.99$32.32-7.63%$33.66$30.811.08 million shs$1.46 billion04/03/2025$37.83$34.99-7.51%$36.74$33.58717,062 shs$1.58 billion04/02/2025$35.61$37.83+6.23%$38.14$35.07720,225 shs$1.70 billion04/01/2025$37.36$35.61-4.68%$37.87$35.24664,956 shs$1.60 billion03/31/2025$39.72$37.36-5.94%$38.95$35.45849,308 shs$1.68 billion03/28/2025$39.25$39.72+1.20%$39.93$38.25415,250 shs$1.79 billion03/27/2025$40.14$39.25-2.22%$41.07$38.91523,402 shs$1.77 billion Related Companies BPMC Stock Chart VRNA Stock Chart NUVL Stock Chart AXSM Stock Chart GRFS Stock Chart CYTK Stock Chart KRYS Stock Chart ELAN Stock Chart PCVX Stock Chart RYTM Stock Chart Receive APGE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Apogee Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:APGE) was last updated on 4/28/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored‘Wheels Are Falling Off’ the U.S. Stock MarketThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apogee Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Apogee Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy APGE Stock Free APGE Stock Alerts